• 1
    Malling H-J. EAACI/PTA symposium reviews. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461472.
  • 2
    Malling H-J, Weeke B. EAACI position paper. Immunotherapy. Allergy 1993;48 Suppl 14:945.
  • 3
    Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs [see comments]. BMJ 1991;302:265269.
  • 4
    Weyer A, Donat N, Heritier C, et al. Grass pollen hyposensitization versus placebo therapy. I. Clinical effectiveness and methodological aspects of a pre-seasonal course of desensitization with a four-grass pollen extract. Allergy 1981;36:309317.
  • 5
    Bousquet J, Becker WM, Hejjaoui A, et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:4353.
  • 6
    Zenner HP, Baumgarten C, Rasp G, et al. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:2329.
  • 7
    Möller C, Dreborg S. Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results. Clin Allergy 1986;16:135143.
  • 8
    Dolz I, Martinez-Cocera C, Bartolome JM, Cimarra M. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996;51:489500.
  • 9
    Petersen BN, Janniche H, Munch EP, et al. Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988;43:353362.
  • 10
    Walker SM, Varney VA, Gaga M, et al. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 1995;50:405413.
  • 11
    Østerballe O. Immunotherapy with grass pollen major allergens. Allergy 1982;37:379388.
  • 12
    Goldberg C, Buch H, Moseholm L, Weeke ER. Airborne pollen records in Denmark, 1977–1986. Grana 1988;27:209217.
  • 13
    Altman DG. Practical statistics for medical research. New York: Chapman & Hall, 1992.
  • 14
    Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974;15:443453.
  • 15
    Jones RH. Longitudinal data with serial correlation: a state-space approach. Monographs on statistics and applied probability. London: Chapman & Hall, 1993.
  • 16
    Winther L, Mosbech H, Malling H-J. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects. Allergy 2000;55:827835.
  • 17
    Mosbech H, Østerballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43:523529.
  • 18
    Østerballe O, Løwenstein H, Norn S, et al. Immunotherapy with grass pollen major allergens. Immunological results from a prospective 3-year double blind study. Allergy 1982;37:491501.
  • 19
    Pastorello EA, Pravettoni V, Incorvaia C, et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 1992;47:281290.
  • 20
    Winther L, Bindslev-Jensen C, Malling H-J. Individual uses of antiallergic drugs for seasonal allergic rhinitis in patients instructed in a stepwise introduction. Allergy 2000;55: (in press).